Cogent Biosciences, Inc. COGT Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cogent Biosciences, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cogent Biosciences, Inc.'s retained earnings?
- Cogent Biosciences, Inc. (COGT) reported retained earnings of -$1.29B in Q1 2026.
- How has Cogent Biosciences, Inc.'s retained earnings changed year-over-year?
- Cogent Biosciences, Inc.'s retained earnings decreased by 38.0% year-over-year, from -$931.47M to -$1.29B.
- What is the long-term trend for Cogent Biosciences, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), Cogent Biosciences, Inc.'s retained earnings has grown at a 43.0% compound annual growth rate (CAGR), from -$198.7M to -$1.19B.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.